Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 376-384

  Rao, Ravi D ^a   Thomé, Stephan D ^a   O'Fallon, Judith ^a   Earle, John D ^a   Dinapoli, Robert P ^a   Buckner, Jan C ^a  

^a MAYO CLINIC   (United States)

Author keywords

BCNU; High grade glioma; Hyperfractionation; Toxicity

Indexed keywords

BIOPSY; DISEASES; DRUG DOSAGE; NEUROLOGY; PATIENT TREATMENT; RADIATION; TOXICITY;

HYPERFRACTIONATED RADIATION;

RADIOTHERAPY;

CARMUSTINE;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; TIME; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; ASTROCYTOMA; BRAIN DISEASES; CARMUSTINE; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; GLIOSARCOMA; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036603621     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02731-1     Document Type: Article

References (36)

1. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial
2. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
3. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group Trial 8001
4. Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group
5. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
6. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma
7. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
8. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma
9. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery: A Southwest Oncology Group Report
10. Recurrent malignant gliomas: Survival following interstitial brachytherapy with high-activity iodine-125 sources
11. Misonidazole combined with hyperfractionation in the management of malignant glioma
12. Superfractionation radiation therapy in the treatment of malignant astrocytoma
13. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
14. Biologic basis for altered fractionation schemes
15. Radiation tolerance of the rat spinal cord: Time-dose relationships
16. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma - Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the Radiation Therapy Oncology Group Protocol 8302
17. Superfractionation in glioblastoma multiforme - Results of a phase II study
18. Malignant astrocytoma: Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial
19. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma: Final report of a prospective phase I-II dose response study
20. Accelerated radiotherapy in glioblastoma multiforme: A dose searching prospective study
21. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma: A preliminary report
22. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas: A pilot feasibility study of the Radiotherapy Group of the EORTC
23. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation Therapy Oncology Group Study 83-02
24. Accelerated hyperfractionated radiation therapy for malignant glioma: A phase II study
25. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma
26. Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma
27. 2, respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients
28. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma: A preliminary report of Radiation Therapy Oncology Group 83-02
29. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: A phase II study
30. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: Results in anaplastic astrocytoma
31. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas
32. Accelerated hyperfractionated radiotherapy for malignant gliomas
33. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: A phase II study
34. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme
35. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: Long-term results of a phase II study
36. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme